Incidence, Microbiology, and Outcomes in Patients Hospitalized With Infective Endocarditis
Top Cited Papers
Open Access
- 23 June 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 141 (25), 2067-2077
- https://doi.org/10.1161/circulationaha.119.044913
Abstract
Background: Despite improvements in management, infective endocarditis remains associated with high mortality and morbidity. We describe temporal changes in the incidence, microbiology and outcomes of infective endocarditis and the impact of changes in national antibiotic prophylaxis guidelines on incident infective endocarditis. Methods: Using a Scotland-wide, individual-level linkage approach, all patients hospitalized with infective endocarditis from 1990 until 2014 were identified and linked to national microbiology, prescribing and morbidity and mortality datasets. Linked data were used to evaluate trends in the crude and age- and sex-adjusted incidence and outcomes of infective endocarditis hospitalizations. From 2008, microbiology data and associated outcomes adjusted for patient demographics and comorbidity were also analyzed. An interrupted time series analysis was performed to evaluate incidence before and after changes to national antibiotic prophylaxis guidelines. Results: There were 7,638 hospitalizations (65±17 years, 51% females) with infective endocarditis. The estimated crude hospitalization rate increased from 5.3/100,000 (95% confidence interval [CI] 4.8-5.9) to 8.6/100,000 (95% CI 8.1-9.1) between 1990 and 1995 but remained stable thereafter. There was no change in crude incidence following the 2008 change in antibiotic prophylaxis guidelines (relative risk of change 1.06, 95% CI 0.94-1.20). The incidence rate in patients >80 years doubled from 1990 to 2014 (17.7/100,000 [95% CI 13.4-23.3] to 37.9/100,000 [95% CI 31.5-45.5]). The predicted 1 year age- and comorbidity-adjusted case fatality rate for a 65 year-old patient decreased in women (27.3% [95% CI 24.6-30.2] to 23.7% [95% CI 21.1 to 26.6]) and men (30.7% [95% CI 27.7-33.8] to 26.8% [95% CI 24.0-29.7]) from 1990 to 2014. Blood culture data were available from 2008 (n=2,267/7,638, 30%), with positive blood cultures recorded in 42% (950/2,267). Staphylococcus (403/950, 42.4%) and streptococcus (337/950, 35.5%) species were most common. Staphylococcus aureus and enterococcus had the highest 1 year mortality (adjusted odds ratio 4.34 [95% CI 3.12-6.05] and 3.41 [95% CI 2.04-5.70], respectively). Conclusions: Despite changes in antibiotic prophylaxis guidelines, the crude incidence of infective endocarditis has remained stable. However, the incidence rate has doubled in the elderly. Positive blood cultures were observed in less than half of patients, with Staphylococcus aureus and enterococcus bacteremia associated with worse outcomes.This publication has 45 references indexed in Scilit:
- Incidence of Infective Endocarditis Caused by Viridans Group Streptococci Before and After Publication of the 2007 American Heart Association's Endocarditis Prevention GuidelinesCirculation, 2012
- Trends in endocarditis hospitalizations at US children's hospitals: Impact of the 2007 American Heart Association Antibiotic Prophylaxis GuidelinesAmerican Heart Journal, 2012
- Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based SurveyClinical Infectious Diseases, 2012
- Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapyClinical Microbiology & Infection, 2011
- Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after studyBMJ, 2011
- Infective endocarditisNature Reviews Cardiology, 2011
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyJAMA Internal Medicine, 2009
- Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)Heart, 2005
- Staphylococcus aureus EndocarditisJAMA, 2005
- Vancomycin-resistant Enterococci: the clinical effect of a common nosocomial pathogenDiagnostic Microbiology and Infectious Disease, 1999